OptimizeRx CEO William Febbo Resigns, Leadership Transition Planned

TipRanksJan 11 05:31

OptimizeRx Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $7 to $6.

BenzingaJan 9 00:53

RBC Capital Downgrades OptimizeRx(OPRX.US) to Hold Rating, Cuts Target Price to $6

Futu NewsJan 8 20:34 · Ratings

RBC Downgrades OptimizeRx to Sector Perform From Outperform, Cuts Price Target to $6 From $7

MT NewswiresJan 8 19:25 · Ratings

Is There An Opportunity With OptimizeRx Corporation's (NASDAQ:OPRX) 49% Undervaluation?

Yahoo FinanceJan 2 19:38

CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

BenzingaDec 24, 2024 22:49